7/1/2020 8:23:07 AM
BioReference Lab Reports Results Of COVID-19 Molecular PCR Tests For Nursing Home And Live-in Facility Employees
6/9/2020 8:15:53 AM
OPKO Health Announces Japan Phase 3 Clinical Trial Met Its Primary And Secondary Objectives
6/1/2020 8:06:39 AM
OPKO Health Says FDA Authorizes Clinical Trial Evaluating RAYALDEE In COVID-19 Patients
5/13/2020 8:34:23 AM
OPKO Health's BioReference Labs, Westchester Medical Center Collaborate To Deliver Operational And Diagnostic Services
3/24/2020 9:11:46 AM
BioReference Laboratories Announces Collaboration With The City Of Miami To Provide COVID-19 Testing
8/29/2019 9:51:03 AM
OPKO Completes Pivotal Phase 3 Study For Somatrogon
7/1/2019 8:06:10 AM
BioReference Laboratories Forms Strategic Collaboration With SOMOS To Improve Health Outcomes Of Underserved New Yorkers
2/5/2019 8:35:08 AM
OPKO Health Reports Pricing Of Offering Of $200 Mln Convertible Senior Notes Due 2025
2/1/2019 8:09:52 AM
OPKO Health Gets FDA Approval For Point-of-Care Sangia PSA Test With Claros 1 Analyzer
1/31/2019 9:17:01 PM
OPKO Provides Update On Development Of OPK-88004, Selective Androgen Receptor Modulator
1/7/2019 6:04:24 AM
OPKO Health Appoints Jon Cohen As Executive Chairman Of BioReference Laboratories